Insider · CIK 0001663771

Ware Olivia C

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001663771

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	CTNMContineum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19K sh	—	—	19,000
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−36.8K sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.5K sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,011 sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,174 sh	—	—	0
2025-06-26	CTNMContineum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14.8K sh	—	—	14,750
2025-05-29	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,174 sh	—	—	9,174
2025-02-06	Revance Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-02-04	Revance Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−16.7K sh	$3.65	−$60.9K	15,000
2024-05-28	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,011 sh	—	—	8,011
2024-05-24	CTNMContineum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,700 sh	—	—	3,700
2024-05-01	Revance Therapeutics, Inc.A Award	Director	AAward	+15K sh	—	—	31,675
2024-05-01	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+23.5K sh	—	—	23,458
2024-04-16	Arcellx, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,402 sh	$7.61	+$71.5K	9,402
2024-04-16	Arcellx, Inc.S Sale	Director	SSale	−6,790 sh	$55.36	−$376K	2,612
2024-04-16	Arcellx, Inc.S Sale	Director	SSale	−2,612 sh	$56.03	−$146K	0
2024-04-16	Arcellx, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,402 sh	—	—	36,806
2024-03-15	Arcellx, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	$7.61	+$68.5K	9,000
2024-03-15	Arcellx, Inc.S Sale	Director	SSale	−1,900 sh	$69.44	−$132K	7,100
2024-03-15	Arcellx, Inc.S Sale	Director	SSale	−3,763 sh	$70.36	−$265K	3,337
2024-03-15	Arcellx, Inc.S Sale	Director	SSale	−3,337 sh	$70.99	−$237K	0
2024-03-15	Arcellx, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,000 sh	—	—	46,208
2023-06-14	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,459
2023-05-03	Revance Therapeutics, Inc.A Award	Director	AAward	+3,534 sh	—	—	16,675
2023-05-03	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+5,915 sh	—	—	5,915
2022-05-16	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+55.2K sh	—	—	55,208
2022-05-04	Revance Therapeutics, Inc.A Award	Director	AAward	+6,059 sh	—	—	13,141
2022-05-04	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,343
2022-05-04	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+10.8K sh	—	—	10,756
2021-05-05	Revance Therapeutics, Inc.A Award	Director	AAward	+674 sh	—	—	7,082
2021-05-05	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+1,268 sh	—	—	1,268
2021-03-08	Revance Therapeutics, Inc.A Award	Director	AAward	+6,408 sh	—	—	6,408
2021-03-08	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+11.2K sh	—	—	11,161
2016-01-11	LADXLadRx Corp · Stock option (right to buy)A Award	Chief Commercial Officer	AAward	+350K sh	—	—	350,000

Recent filings

Accepted (ET)
Jun 264
Ware Olivia C0001628280-26-045841
SEC(opens sec.gov)
Apr 284
Ware Olivia C0001663771-26-000002
SEC(opens sec.gov)
Jun 264
Ware Olivia C0001437749-25-021366
SEC(opens sec.gov)
May 304
Ware Olivia C0001415889-25-014986
SEC(opens sec.gov)
Feb 64
Ware Olivia C0000950170-25-015354
SEC(opens sec.gov)
Jun 64
Ware Olivia C0001415889-24-015745
SEC(opens sec.gov)
May 294
Ware Olivia C0001437749-24-018621
SEC(opens sec.gov)
May 34
Ware Olivia C0001479290-24-000090
SEC(opens sec.gov)
Apr 184
Ware Olivia C0001415889-24-011120
SEC(opens sec.gov)
Mar 184
Ware Olivia C0001415889-24-008340
SEC(opens sec.gov)

Companies

Address

3565 GENERAL ATOMICS COURT, SUITE 200

SAN DIEGO, CA, 92121